{"id":"W2117722893","doi":"10.1186/2008-2231-21-50","title":"Cost-effectiveness of different interferon beta products for relapsing-remitting and secondary progressive multiple sclerosis: Decision analysis based on long-term clinical data and switchable treatments","year":2013,"lang":"en","type":"article","venue":"DARU Journal of Pharmaceutical Sciences","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute for Clinical Evaluative Sciences","funders":"Tehran University of Medical Sciences and Health Services","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Interferon beta-1b; Quality-adjusted life year; Interferon beta-1a; Interferon beta; Biosimilar; Quality of life (healthcare); Cost effectiveness; Relapsing remitting; Internal medicine; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003941511,0.000209899,0.0008415144,0.000344678,0.0002413263,0.0001120903,0.0003620829,0.00006886412,0.00004441915],"category_scores_gemma":[0.003436502,0.0001223343,0.0001403629,0.0004672387,0.0009715216,0.0004192978,0.000339359,0.0003667843,6.443047e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007209312,"about_ca_system_score_gemma":0.000142722,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008428091,"about_ca_topic_score_gemma":0.000003604556,"domain_scores_codex":[0.9970608,0.000398826,0.0007937672,0.000572045,0.0007984574,0.0003760762],"domain_scores_gemma":[0.9938828,0.004483987,0.0004412252,0.000291982,0.0005254402,0.0003745467],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002121839,0.0008882203,0.7226167,0.0003381164,0.0007306355,0.000005986405,0.00005895878,0.00001620505,0.02050249,0.000001581926,0.0000874144,0.2526318],"study_design_scores_gemma":[0.006501739,0.003018935,0.92252,0.001914653,0.001029648,0.00001092233,0.0001076242,0.04535759,0.01939339,0.00001660655,0.00001657511,0.0001123063],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936113,0.002092507,0.001741592,0.0006932855,0.0001604327,0.001618047,0.00005775838,0.000006832845,0.00001821646],"genre_scores_gemma":[0.994382,0.0009992692,0.004387295,0.00006475249,0.0000945087,0.00004190572,0.00001680423,0.000009908657,0.000003579132],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2525195,"threshold_uncertainty_score":0.4988647,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3454514862041025,"score_gpt":0.4921742077763072,"score_spread":0.1467227215722047,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}